Assignee
BIOGEN INC
US·125 granted patents·20 pending applications·7,812 citations·filing 1985–2021
Top patents by PatentIndex Score
145 records- 0199US4873316AIsolation of exogenous recombinant proteins from the milk of transgenic mammalsBIOGEN INC·Filed 1987·Granted Oct 10, 1989·1.3k cites·3 claims
- 0298US5747641ATat-derived transport polypeptide conjugatesBIOGEN INC·Filed 1995·Granted May 5, 1998·319 cites·5 claims
- 0398US5674980AFusion protein comprising tat-derived transport moietyBIOGEN INC·Filed 1995·Granted Oct 7, 1997·349 cites·10 claims
- 0497US7112665B1Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plantsBIOGEN INC·Filed 1995·Granted Sep 26, 2006·371 cites·2 claims
- 0597US6602503B1Recombinant anti-VLA-4 antibody moleculesBIOGEN INC·Filed 1995·Granted Aug 5, 2003·183 cites·146 claims
- 0697US5804604ATat-derived transport polypeptides and fusion proteinsBIOGEN INC·Filed 1995·Granted Sep 8, 1998·470 cites·14 claims
- 0796US5670617ANucleic acid conjugates of tat-derived transport polypeptidesBIOGEN INC·Filed 1995·Granted Sep 23, 1997·189 cites·4 claims
- 0895US6162432AMethod of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interactionBIOGEN INC·Filed 1995·Granted Dec 19, 2000·159 cites·55 claims
- 0995US5109124ANucleic acid probe linked to a label having a terminal cysteineBIOGEN INC·Filed 1989·Granted Apr 28, 1992·906 cites·7 claims
- 1095US4956288AMethod for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNABIOGEN INC·Filed 1988·Granted Sep 11, 1990·225 cites·20 claims
- 1194US5272263ADNA sequences encoding vascular cell adhesion molecules (VCAMS)BIOGEN INC·Filed 1989·Granted Dec 21, 1993·72 cites·9 claims
- 1293US6861509B1Antibodies to Ret and RetL3BIOGEN INC·Filed 2000·Granted Mar 1, 2005·43 cites·4 claims
- 1393US5932214ATreatment for inflammatory bowel disease with VLA-4 blockersBIOGEN INC·Filed 1997·Granted Aug 3, 1999·90 cites·15 claims
- 1493US5925351ASoluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseaseBIOGEN INC·Filed 1995·Granted Jul 20, 1999·78 cites·16 claims
- 1592US5545723AMuteins of IFN-βBIOGEN INC·Filed 1994·Granted Aug 13, 1996·60 cites·15 claims
- 1691US6764681B2Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interactionBIOGEN INC·Filed 2000·Granted Jul 20, 2004·39 cites·57 claims
- 1791US6664385B1Kidney injury-related moleculesBIOGEN INC·Filed 1998·Granted Dec 16, 2003·88 cites·19 claims
- 1891US5888507ATreatment for insulin dependent diabetesBIOGEN INC·Filed 1995·Granted Mar 30, 1999·87 cites·14 claims
- 1991US5196404AInhibitors of thrombinBIOGEN INC·Filed 1990·Granted Mar 23, 1993·84 cites·37 claims
- 2091US5169936AProtein purification on immobilized metal affinity resins effected by elution using a weak ligandBIOGEN INC·Filed 1989·Granted Dec 8, 1992·104 cites·32 claims
- 2191US5168049AProduction of streptavidin-like polypeptidesBIOGEN INC·Filed 1988·Granted Dec 1, 1992·95 cites·35 claims
- 2290US6652856B2Method for the treatment of fibrosisBIOGEN INC·Filed 2002·Granted Nov 25, 2003·34 cites·8 claims
- 2390US5547853ACD2-binding domain of lymphocyte function associated antigen 3BIOGEN INC·Filed 1992·Granted Aug 20, 1996·66 cites·35 claims
- 2490US4956281ADNA sequences, recombinant DNA molecules and processes for producing lymphocyte function associated antigen-3BIOGEN INC·Filed 1987·Granted Sep 11, 1990·108 cites·10 claims
- 2588US6962978B2Polymer conjugates of interferon beta-1a and usesBIOGEN INC·Filed 2001·Granted Nov 8, 2005·29 cites·24 claims
- 2688US6649600B1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2000·Granted Nov 18, 2003·31 cites·38 claims
- 2788US6627202B2HBV core antigen particles with multiple immunogenic components attached via peptide ligandsBIOGEN INC·Filed 2001·Granted Sep 30, 2003·25 cites·41 claims
- 2888US6403087B1Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological diseaseBIOGEN INC·Filed 1996·Granted Jun 11, 2002·52 cites·14 claims
- 2988US5871734ATreatment for asthma with VLA-4 blocking agentsBIOGEN INC·Filed 1997·Granted Feb 16, 1999·58 cites·22 claims
- 3088US5487984AProcesses for producing tumor necrosis factorBIOGEN INC·Filed 1985·Granted Jan 30, 1996·58 cites·11 claims
- 3188US5367056AEndothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)BIOGEN INC·Filed 1993·Granted Nov 22, 1994·50 cites·6 claims
- 3288US5223394ARecombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequenceBIOGEN INC·Filed 1989·Granted Jun 29, 1993·63 cites·15 claims
- 3387US6482409B1Treatment for inflammatory bowel disease with a vcam-1/1gG fusion proteinBIOGEN INC·Filed 1998·Granted Nov 19, 2002·48 cites·11 claims
- 3486US6669941B1Soluble lymphotoxin-β receptor as a therapeutic agent for treating TH-1 cell-associated autoimmune diseaseBIOGEN INC·Filed 1999·Granted Dec 30, 2003·42 cites·14 claims
- 3586US6252043B1Vascular cell adhesion molecule (VCAM) polypeptidesBIOGEN INC·Filed 1994·Granted Jun 26, 2001·47 cites·5 claims
- 3685US5256559AMethods and compositions for inhibiting platelet aggregationBIOGEN INC·Filed 1991·Granted Oct 26, 1993·66 cites·16 claims
- 3784US7173046B2CD40:CD154 binding interrupter compounds and use thereof to treat immunological complicationsBIOGEN INC·Filed 2003·Granted Feb 6, 2007·22 cites·6 claims
- 3884US6605600B1Adenosine receptor antagonists and methods of making and using the sameBIOGEN INC·Filed 2000·Granted Aug 12, 2003·18 cites·29 claims
- 3984US5217870AMonoclonal antibodies against CDXBIOGEN INC·Filed 1989·Granted Jun 8, 1993·48 cites·3 claims
- 4083US5871732AAnti-CD4 antibody homologs useful in prophylaxis and treatment of AIDS, ARC and HIV infectionBIOGEN INC·Filed 1991·Granted Feb 16, 1999·68 cites·21 claims
- 4183US5795964ALymphotoxin-beta and lymphotoxin-beta complexesBIOGEN INC·Filed 1995·Granted Aug 18, 1998·37 cites·11 claims
- 4283US5670149ALymphotoxin-β, Lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereofBIOGEN INC·Filed 1995·Granted Sep 23, 1997·38 cites·3 claims
- 4382US6307025B1VCAM fusion proteins and DNA coding thereforBIOGEN INC·Filed 1995·Granted Oct 23, 2001·35 cites·7 claims
- 4482US5219990APapillomavirus e2 trans-activation repressorsBIOGEN INC·Filed 1991·Granted Jun 15, 1993·37 cites·6 claims
- 4582US4895716AStabilized formulations of gamma interferonsBIOGEN INC·Filed 1987·Granted Jan 23, 1990·30 cites·14 claims
- 4682US4879224ADNA sequences, recombinant DNA molecules and processes for producing human phospholipase inhibitor polypeptidesBIOGEN INC·Filed 1985·Granted Nov 7, 1989·44 cites·9 claims
- 4781US6696423B1Methods and compositions for therapies using genes encoding secreted proteins such as interferon-betaBIOGEN INC·Filed 2000·Granted Feb 24, 2004·14 cites·12 claims
- 4881US6677135B1Ret ligand (RetL) for stimulating neutral and renal growthBIOGEN INC·Filed 1998·Granted Jan 13, 2004·30 cites·10 claims
- 4981US5433940AInhibitors of thrombinBIOGEN INC·Filed 1990·Granted Jul 18, 1995·36 cites·17 claims
- 5080US6495525B1VLA-4 inhibitor: oMePUPA-VBIOGEN INC·Filed 2000·Granted Dec 17, 2002·13 cites·19 claims
Showing the top 50 of 145 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →